Drug Trial Radar · NCT01289015
Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis
Last checked: Nov 20, 2026Latest source record: Sep 26, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
855
Actual
Start
Feb 2011
Primary completion
Nov 2011
Study completion Jan 2012
Sponsor
- Lead sponsor
- Merz North America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 3, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of NAFT-600, applied once daily for 2 weeks, when compared to placebo for 2 weeks in the treatment of subjects with tinea pedis.
Conditions
- Tinea Pedis
Interventions
NAFT-600 ( naftin 2 % gel )Drug
Topical; applied once daily for two weeks
PlaceboDrug
Topical; applied once daily for two weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Cure of Interdigital Tinea PedisTime frame: Visit 4/ Week 6
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Associated Foot & Ankle Specialists, LLC
Phoenix, Arizona
Skin Surgery Medical Group, Inc.
San Diego, California
UCSF Dermatology Research
San Francisco, California
The Savin Center, PC
New Haven, Connecticut
Avail Clinical Research
DeLand, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
International Dermatology Research, Inc.
Miami, Florida
Miami Dermatology Research Institute, LLC
North Miami Beach, Florida
Radiant Research, Inc.
Pinellas Park, Florida
Northwest Clinical Trials
Boise, Idaho
Physician Skin Care
Louisville, Kentucky
Michigan Center for Skin Care Research
Clinton Township, Michigan
Henry Ford Hospital
Detroit, Michigan
Minnesota Clinical Study Center
Fridley, Minnesota
Skin Search of Rochester, Inc.
Rochester, New York
Crescent Medical Research
Salisbury, North Carolina
Wake Forest University Health Sciences
Winston-Salem, North Carolina
Paddington Testing Co., Inc.
Philadelphia, Pennsylvania
Tennessee Clinical Research Center
Nashville, Tennessee
DermResearch, Inc.
Austin, Texas
The Center for Skin Research
Houston, Texas
Endeavor Clinical Trials, PA
San Antonio, Texas
Advanced Medical Concepts, PSC
Cidra, PR, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.